TRPM2 Exacerbates Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis by Increasing Production of CXCL2 Chemokines

Multiple sclerosis (MS) is a chronic inflammatory disorder of the CNS characterized by demyelination and axonal injury. Current therapies that mainly target lymphocytes do not fully meet clinical need due to the risk of severe side effects and lack of efficacy against progressive MS. Evidence sugges...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Neurosci
Päätekijät: Tsutsui, Masato, Hirase, Ryo, Miyamura, Sakie, Nagayasu, Kazuki, Nakagawa, Takayuki, Mori, Yasuo, Shirakawa, Hisashi, Kaneko, Shuji
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Society for Neuroscience 2018
Aiheet:
Research Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6596171/
https://ncbi.nlm.nih.gov/pubmed/30201769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.2203-17.2018
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia